Subscribe to our Nanotechnology Business News feed
Nova's technology was chosen to support 14 and 11nm technology nodes development and future manufacturing, covering FEOL and BEOL applications for litho, etch and CMP processes.
Posted: Jan 12th, 2012
Read more
Heliotis and Digital Surf announced that MountainsMap Imaging Topography surface metrology software based upon Digital Surf's Mountains Technology will be supplied with Heliotis M3 and M3-XL 3D Optical Profilers.
Posted: Jan 11th, 2012
Read moreEVG will integrate Eulitha's PHABLE mask-based ultraviolet (UV) photolithography technology with EVG's automated mask aligner product platform with the goal of developing a low-cost-of-ownership (CoO) nanopatterning solution to enable the production of high-brightness light emitting diodes (HB-LEDs).
Posted: Jan 10th, 2012
Read moreDelong America is pleased to announce that we will have the LVEM5 benchtop electron microscope on display at the 10th Asia-Pacific Microscopy Conference (APMC 10), the 2012 International Conference on Nanoscience and Nanotechnology (ICONN 2012) and the 22nd Australian Conference on Microscopy and Microanalysis (ACMM 22).
Posted: Jan 10th, 2012
Read more
Harvard Medical School team uses Andor Revolution DSD confocal for simultaneous measurement of intracellular pH and ATP in live cells.
Posted: Jan 10th, 2012
Read more
With the kinetic spectroscopy package, this system is able to monitor the full range spectra of a microscopic sample area over time and plot the results.
Posted: Jan 10th, 2012
Read moreBritish Airways is to extend a trial of an innovative paint coating designed to improve fuel efficiency in a move that could save the airline millions of pounds in fuel costs.
Posted: Jan 9th, 2012
Read moreNanometrics Incorporated, a leading supplier of advanced process control systems and solutions, today announced a significant milestone marking the adoption of its optical critical dimension (OCD) technology.
Posted: Jan 9th, 2012
Read moreFEI, a leading instrumentation company providing imaging and analysis systems for research and industry, today announced that it has acquired ASPEX Corporation of Delmont, PA. ASPEX provides rugged scanning electron microscopes (SEMs) and related services for environmentally demanding military, industrial and factory floor applications.
Posted: Jan 9th, 2012
Read moreGT Advanced Technologies Inc., today announced that it has received a $101.3 million dollar order for CVD reactors and ancillary production equipment from an incumbent polysilicon producer.
Posted: Jan 9th, 2012
Read moreTempe, Arizona based SDCmaterials, the global leader in development of advanced high performance catalyst materials, is pleased to announce the commencement of field trials for their novel Nano-Nano-Micron (NNm) emission control catalyst product.
Posted: Jan 9th, 2012
Read moreThe launch will focus on the commercialization, via partnering or licensing, of products that have combined the IP of the companies' respective technologies in the primary treatment of diabetes.
Posted: Jan 9th, 2012
Read moreIntertek Cantox, a leading provider of scientific and regulatory consulting services to the food, chemical, and pharmaceutical industries, announces the development of a method to promote high quality nanotoxicology studies allowing companies to ensure the safety of nanotechnology and nanomaterials based products entering the market.
Posted: Jan 9th, 2012
Read moreBlend Therapeutics, a biotechnology company discovering and developing a new class of integrative combination medicines, announced the company's founding and strategic mission to develop innovative combination medicines with novel pharmacological profiles designed to target distinct disease pathways with optimal efficacy and safety.
Posted: Jan 6th, 2012
Read moreAlnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and Arrowhead Research Corporation, a nanomedicine company with development programs in RNAi and obesity, announced today that they have entered into a collaboration and joint licensing agreement.
Posted: Jan 5th, 2012
Read moreArrowhead Research Corporation, a nanomedicine company with development programs in oncology and obesity, today announced that the Investigational New Drug Application (IND) for its first obesity drug candidate, Adipotide, was accepted by the U.S. Food and Drug Administration allowing the initiation of a clinical trial to test the safety of the compound.
Posted: Jan 4th, 2012
Read more